Vir Biotechnology Inc Annual Shareholders Meeting Transcript
Good morning, and welcome to the Vir Biotechnology, Inc., Annual Meeting of Stockholders.
It is now my pleasure to turn over today's meeting to Dr. Marianne De Backer, President and CEO of Vir Biotechnology. Dr. De Backer, the floor is yours.
Good morning. I'm Marianne De Backer, President and Chief Executive Officer of Vir Biotechnology. I would like to welcome all of you to Vir Biotechnology's 2026 Annual Meeting of Stockholders. As you know, we are hosting today's meeting through a virtual online platform. We have designed this meeting to provide stockholders with the same rights and opportunities to participate as they would at an in-person meeting.
Before I call the meeting to order, I'd like to take this opportunity to introduce you to the members of the Vir Biotechnology Board who are joining me today. They are Jeffrey Hatfield, Chair of our Nominating and Corporate Governance Committee and Member of our Audit Committee; Robert More, Chair of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
